Denali Therapeutics Inc. - stock earnings
DNLI Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| Aug. 6, 2024 BeforeMarket | - / - | - | - / 13.8 million | 32.5 million |
DNLI Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -119.5 million USD | ? USD |
| 2023Q3 | -99.4 million USD | 1.3 million USD |
| 2023Q2 | 183.4 million USD | 294.1 million USD |
| 2023Q1 | -109.8 million USD | 35.1 million USD |
| 2022Q4 | -98.7 million USD | 10.3 million USD |
| 2022Q3 | -103.3 million USD | 3.6 million USD |
| 2022Q2 | -58.8 million USD | 52.5 million USD |
| 2022Q1 | -63.9 million USD | 42.1 million USD |
| 2021Q4 | -75.3 million USD | 12.5 million USD |
| 2021Q3 | -84.6 million USD | 5.3 million USD |
| 2021Q2 | -60.7 million USD | 22.9 million USD |
| 2021Q1 | -70.0 million USD | 7.9 million USD |
| 2020Q4 | 244.9 million USD | 316.8 million USD |
| 2020Q3 | -58.2 million USD | 9.4 million USD |
| 2020Q2 | -58.8 million USD | 5.8 million USD |
| 2020Q1 | -56.8 million USD | 3.6 million USD |
| 2019Q4 | -54.0 million USD | 4.7 million USD |
| 2019Q3 | -46.3 million USD | 13.6 million USD |
| 2019Q2 | -58.3 million USD | 4.2 million USD |
| 2019Q1 | -39.0 million USD | 4.2 million USD |
| 2018Q4 | 77.5 million USD | 125.7 million USD |
| 2018Q3 | -35.4 million USD | 1.2 million USD |
| 2018Q2 | -54.7 million USD | 1.6 million USD |
| 2018Q1 | -23.7 million USD | 641000 USD |
| 2017Q4 | -22.9 million USD | 145.1 million USD |
| 2017Q3 | -21.8 million USD | ? USD |
| 2017Q2 | -22.1 million USD | ? USD |
| 2017Q1 | -21.3 million USD | ? USD |
| 2016Q4 | -19.4 million USD | ? USD |
| 2015Q4 | -16.8 million USD | ? USD |
DNLI Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -145.2 million USD | 330.5 million USD |
| 2022 | -326.0 million USD | 108.5 million USD |
| 2021 | -290.6 million USD | 48.7 million USD |
| 2020 | 71.1 million USD | 335.7 million USD |
| 2019 | -197.6 million USD | 26.7 million USD |
| 2018 | -36.2 million USD | 129.2 million USD |
| 2017 | -88.2 million USD | ? USD |
| 2016 | -86.7 million USD | ? USD |
| 2015 | -16.8 million USD | ? USD |
DNLI
Price: $18.10
52 week price:
Earnings Per Share: -0.94 USD
P/E Ratio: -19.20
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 517900
Market Capitalization: 2.9 billion